Association of diabetes and tuberculosis: Impact on treatment and post-treatment outcomes

Thorax

Volumn 68, Issue 3, 2013, Pages 214-220

  Jiménez Corona, María Eugenia ^a   Cruz Hervert, Luis Pablo ^b   García García, Lourdes ^b   Ferreyra Reyes, Leticia ^b   Delgado Sánchez, Guadalupe ^b   Bobadilla Del Valle, Miriam ^c   Canizales Quintero, Sergio ^b   Ferreira Guerrero, Elizabeth ^b   Báez Saldaña, Renata ^b   Téllez Vázquez, Norma ^b   Montero Campos, Rogelio ^b   Mongua Rodriguez, Norma ^b   Martínez Gamboa, Rosa Areli ^c   Sifuentes Osornio, José ^c   Ponce De León, Alfredo ^c  

^a Laboratorios de Biológicos y Reactivos de Mexico BIRMEX   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; GLUCOSE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DIRECTLY OBSERVED THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEXICO; MICROBIOLOGICAL EXAMINATION; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RECURRENT INFECTION; REINFECTION; RELAPSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPUTUM ANALYSIS; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 84873703696     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201756     Document Type: Article

References (35)

1. World Health Organization. Diabetes. Fact sheet Number 312. August 2011. http://www.who.int/mediacentre/factsheets/fs312/en/index.html (accessed Nov 2011).
2. World Health Organization. Global tuberculosis report 2012. http://www.who.int/tb/publications/global-report/en/index.html (accessed Oct 2011).
3. Jeon CY, Murray MB Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5: e152.
4. World Health Organization. Collaborative framework for care and control of tuberculosis and diabetes. http://www.who.int/diabetes/publications/tb- diabetes2011/en/index.html (accessed Nov 2011).
5. Baker MA, Harries AD, Jeon C.Y., et al The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011; 9: 81.
6. Harries AD, Murray MB, Jeon C.Y., et al Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health 2010; 15: 659-63.
7. Ponce-De-Leon A, Garcia-Garcia M, Mde L, Garcia-Sancho MC, et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004; 27: 1584-90.
8. Instituto Nacional de Estadística, Geografía, e Informática (INEGI). XIII Censo General de Población y Vivienda 2010). México 2011. http://www.inegi.gob.mx (accessed May 2011).
9. Modificación a la Norma Oficial Mexicana NOM-006-SSA2-1993, para la prevención y control de la tuberculosis en la atención primaria a la salud: Secretaria de Salud, Diario Oficial de la Federación, Mexico, 2000.
10. World Health Organization, et al. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 2001; 5: 213-15.
11. Garcia-Garcia Mde L, Ponce-De-Leon A, Garcia-Sancho MC, et al. Tuberculosis-related deaths within a well-functioning DOTS control program. Emerg Infect Dis 2002; 8: 1327-32.
12. Norma Oficial Mexicana NOM-010-SSA2-2010, Para la prevención y el control de la infección por Virus de la Inmunodeficiencia Humana. Secretaria de Salud, Diario Oficial de la Federación, Mexico, 2010.
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35(SUPPL. 1): S64-71.
14. Pfyffer G, Palicova F. Mycobacterium: general characteristics, laboratory detection, and staining procedures. In: Versalovic J, Carrol K, Funke G, et al. eds. Manual of Clinical Microbiology. 10th edn. Washington, D.C: ASM Press, 2011: 472-502.
15. Barlow RE, Gascoyne-Binzi DM, Gillespie S.H., et al Comparison of variable number tandem repeat and IS6110-restriction fragment length polymorphism analyses for discrimination of high- and low-copy-number IS6110 Mycobacterium tuberculosis isolates. J Clin Microbiol 2001; 39: 2453-7.
16. Mathema B, Kurepina NE, Bifani P.J., et al Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 2006; 19: 658-85.
17. Secretaría de Salud. Encuesta Nacional de Adicciones 2008. México 2009 http://www.insp.mx/encuesta-nacional-de-adicciones-2008.html (accessed May 2011).
18. Restrepo BI, Fisher-Hoch SP, Crespo J.G., et al Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 2007; 135: 483-91.
19. Alisjahbana B, van Crevel R, Sahiratmadja E, et al Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 2006; 10: 696-700.
20. Singla R, Khan N, Al-Sharif N, et al Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 2006; 10: 74-9.
21. Perez-Guzman C., Torres-Cruz A, Villarreal-Velarde H, et al Atypical radiological images of pulmonary tuberculosis in 192 diabetic patients: a comparative study. Int J Tuberc Lung Dis 2001; 5: 455-61.
22. Tatar D, Senol G, Alptekin S., et al Tuberculosis in diabetics: features in an endemic area. Jpn J Infect Dis 2009; 62: 423-7.
23. Wang CS, Yang CJ, Chen H.C., et al Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 2009; 137: 203-10.
24. Alisjahbana B, Sahiratmadja E, Nelwan E.J., et al The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007; 45: 428-35.
25. Bock NN, Jensen PA, Miller B, et al Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment. J Infect Dis 2007; 196(SUPPL. 1): S108-13.
26. Wang CH, Yu CT, Lin H.C., et al Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuberc Lung Dis 1999; 79: 235-42.
27. van Exel E., Gussekloo J, de Craen AJ, et al Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus study. Diabetes 2002; 51: 1088-92.
28. Tsukaguchi K, Okamura H, Matsuzawa K., et al (Longitudinal assessment of IFN-gamma production in patients with pulmonary tuberculosis complicated with diabetes mellitus). Kekkaku: (Tuberculosis) 2002; 77: 409-13.
29. Tsukaguchi K, Yoneda T, Yoshikawa M., et al (Case study of interleukin-1 beta, tumor necrosis factor alpha and interleukin-6 production peripheral blood monocytes in patients with diabetes mellitus complicated by pulmonary tuberculosis). Kekkaku: (Tuberculosis) 1992; 67: 755-60.
30. Restrepo BI, Fisher-Hoch SP, Pino P.A., et al Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 2008; 47: 634-41.
31. Santo AH. Deaths attributed to multiple causes and involving tuberculosis in the state of Rio de Janeiro Brazil between 1999 and 2001. J Bras Pneumol 2006; 32: 544-52.
32. Oursler KK, Moore RD, Bishai W.R., et al Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 2002; 34: 752-9.
33. Sanchez-Perez H., Flores-Hernandez J, Jansa J., et al Pulmonary tuberculosis and associated factors in areas of high levels of poverty in Chiapas, Mexico. Int J Epidemiol 2001; 30: 386-93.
34. Centers for Disease Control and Prevention (CDC). Self-reported prevalence of diabetes among Hispanics-United States, 1994-1997. MMWR Morb Mortal Wkly Rep 1999; 48: 8-12.
35. Stevenson CR, Forouhi NG, Roglic G, et al Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007; 7: 234.